ROTHKREUZ, Switzerland – Align Technology, Inc. (NASDAQ:ALGN), a medical device company with a current market cap of $12.1 billion, has announced the launch of Align X-ray Insights in the EU and UK. The new software tool uses artificial intelligence to automatically analyze 2D dental x-rays and is designed to improve diagnostic accuracy and patient care. The company currently maintains a high gross margin of 70% and has low debt levels, according to InvestingPro analysis, and appears to be undervalued.
The Align X-ray Insights software is part of the Align digital platform, which is designed to assist physicians in diagnosing oral health conditions, standardize analysis, and streamline workflow. Early user surveys show that 95% of users find the software helpful in communicating oral health conditions to patients, and 91% report an increase in patient trust and treatment acceptance after using the software. Want deeper insights? InvestingPro subscribers can get exclusive analysis on ALGN’s market position and growth potential, as well as 10 additional professional recommendations.
Align X-ray Insights offers features such as detailed reporting, automated dental charting and color overlays to identify dental anomalies. It is able to detect caries, apical radiolucencies, periodontal bone loss and other symptoms. The software complements the Align Oral Health Suite, providing a digital framework for oral health discussions.
Following the acquisition of dentalXrai GmbH in 2022, Align Technology will integrate its flagship product into the Align digital platform. The cloud-based software will be generally available in the EU and UK from March 25, 2025, and will be on display at the IDS Dental Show in Cologne, Germany, March 25-29, 2025. Integration with iTero intraoral scanners is in progress and will be available in limited quantities.
In other recent news, Align Technology reported fourth-quarter earnings that were slightly below analyst expectations. The company reported adjusted earnings per share of $2.44, just below the consensus estimate of $2.46, and revenue of $995.2 million, below expectations of $1 billion. Align Technology also provided first-quarter guidance, predicting revenue between $965 million and $985 million, below Wall Street expectations of $1.03 billion. Despite these challenges, the company’s clear aligner shipments increased 6.1% year-over-year to 628,730 cases. Align reports full-year 2024 revenue of $4 billion, up 3.5% from 2023, with similar growth in clear aligner shipments.
Related topics:
